Contrast‐enhancing regions of GBM also had significantly higher levels of HOMX1, LTF, and STEAP3 compared to nonenhancing tissues with abnormal FLAIR signals (Figure 4L). The gene discussed is STEAP3; the disease is glioblastoma.